INTRODUCTION: Differential item functioning (DIF) analyses can be used to explore translation, cultural, gender or other differences in the performance of quality of life (QoL) instruments. These analyses are commonly performed using "baseline" or pretreatment data. We previously reported DIF analyses to examine the pattern of item responses for translations of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 QoL instrument, using only data collected prior to cancer treatment. We now compare the consistency of these results with similar analyses of on-treatment and off-treatment assessments and explore whether item relationships differ from those at baseline. METHODS: Logistic regression DIF analyses were used to examine the translation of each item in each multi-item scale at the three time points, after controlling for the overall scale score and other covariates. The consistency of results at the three time points was explored. RESULTS: For most EORTC QLQ-C30 subscales, the DIF results were very consistent across the three time points. Results for the Nausea and Vomiting scale varied the most across assessments. DISCUSSION: The results indicated that DIF analyses were stable across each time point and that the same DIF effects were usually found regardless of the treatment status of the respondent.
INTRODUCTION: Differential item functioning (DIF) analyses can be used to explore translation, cultural, gender or other differences in the performance of quality of life (QoL) instruments. These analyses are commonly performed using "baseline" or pretreatment data. We previously reported DIF analyses to examine the pattern of item responses for translations of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 QoL instrument, using only data collected prior to cancer treatment. We now compare the consistency of these results with similar analyses of on-treatment and off-treatment assessments and explore whether item relationships differ from those at baseline. METHODS: Logistic regression DIF analyses were used to examine the translation of each item in each multi-item scale at the three time points, after controlling for the overall scale score and other covariates. The consistency of results at the three time points was explored. RESULTS: For most EORTC QLQ-C30 subscales, the DIF results were very consistent across the three time points. Results for the Nausea and Vomiting scale varied the most across assessments. DISCUSSION: The results indicated that DIF analyses were stable across each time point and that the same DIF effects were usually found regardless of the treatment status of the respondent.
Authors: N W Scott; P M Fayers; N K Aaronson; A Bottomley; A de Graeff; M Groenvold; M Koller; M A Petersen; M A G Sprangers Journal: Qual Life Res Date: 2006-11-16 Impact factor: 4.147
Authors: Neil W Scott; Peter M Fayers; Neil K Aaronson; Andrew Bottomley; Alexander de Graeff; Mogens Groenvold; Chad Gundy; Michael Koller; Morten A Petersen; Mirjam A G Sprangers Journal: J Clin Epidemiol Date: 2008-09-06 Impact factor: 6.437
Authors: N W Scott; P M Fayers; A Bottomley; N K Aaronson; A de Graeff; M Groenvold; M Koller; M A Petersen; M A G Sprangers Journal: Qual Life Res Date: 2006-08 Impact factor: 4.147
Authors: Neil W Scott; Josephine A Etta; Neil K Aaronson; Andrew Bottomley; Peter M Fayers; Mogens Groenvold; Michael Koller; Dagmara Kuliś; Debbi Marais; Morten A Petersen; Mirjam A G Sprangers Journal: Qual Life Res Date: 2012-10-02 Impact factor: 4.147
Authors: Kathryn M Field; Madeleine T King; John Simes; David Espinoza; Elizabeth H Barnes; Kate Sawkins; Mark A Rosenthal; Lawrence Cher; Elizabeth Hovey; Helen Wheeler; Anna K Nowak Journal: J Neurooncol Date: 2017-05-22 Impact factor: 4.130
Authors: Björn Löppenberg; Christian von Bodman; Marko Brock; Florian Roghmann; Joachim Noldus; Rein Jüri Palisaar Journal: Qual Life Res Date: 2014-06-06 Impact factor: 4.147
Authors: Bethany Russell; Anna Collins; Michael Dally; Anthony Dowling; Michelle Gold; Michael Murphy; Jennifer Philip Journal: J Neurooncol Date: 2014-07-01 Impact factor: 4.130